Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 16-Apr-24 4:13 PM View:  | Luciano Juan R Director | Eli Lilly & Co. (LLY) | 15-Apr-24 | Grant | 20 | $750.77 | $15,015.40 | < 1% 15.66K to 15.68K | |
| 16-Apr-24 4:11 PM View: | Hedley Mary Lynne Director | Eli Lilly & Co. (LLY) | 15-Apr-24 | Grant | 13 | $750.77 | $9,760.01 | < 1% 1.56K to 1.57K | |
| 16-Apr-24 4:12 PM View: | Johnson Kimberly H Director | Eli Lilly & Co. (LLY) | 15-Apr-24 | Grant | 13 | $750.77 | $9,760.01 | < 1% 2.61K to 2.63K | |
| 16-Apr-24 4:10 PM View: | Alvarez Ralph Director | Eli Lilly & Co. (LLY) | 15-Apr-24 | Grant | 16 | $750.77 | $12,012.30 | < 1% 54.01K to 54.03K | |
| 16-Apr-24 4:14 PM View: | Greene Gabrielle E Director | Eli Lilly & Co. (LLY) | 15-Apr-24 | Grant | 13 | $750.77 | $9,760.01 | < 1% 2.12K to 2.13K | |
| 19-Mar-24 4:23 PM View: | Greene Gabrielle E Director | Eli Lilly & Co. (LLY) | 18-Mar-24 | Grant | 13 | $762.66 | $9,914.58 | < 1% 2.1K to 2.12K | |
| 19-Mar-24 4:21 PM View: | Luciano Juan R Director | Eli Lilly & Co. (LLY) | 18-Mar-24 | Grant | 19 | $762.66 | $14,490.50 | < 1% 15.64K to 15.66K | |
| 19-Mar-24 4:17 PM View: | Hedley Mary Lynne Director | Eli Lilly & Co. (LLY) | 18-Mar-24 | Grant | 13 | $762.66 | $9,914.58 | < 1% 1.55K to 1.56K | |
| 19-Mar-24 4:19 PM View: | Johnson Kimberly H Director | Eli Lilly & Co. (LLY) | 18-Mar-24 | Grant | 13 | $762.66 | $9,914.58 | < 1% 2.6K to 2.61K | |
| 19-Mar-24 4:15 PM View: | Alvarez Ralph Director | Eli Lilly & Co. (LLY) | 18-Mar-24 | Grant | 15 | $762.66 | $11,439.90 | < 1% 54.0K to 54.01K | |
| 11-Mar-24 4:27 PM View: | Zakrowski Donald A SVP, Finance, & CAO | Eli Lilly & Co. (LLY) | 11-Mar-24 | Private Sale (Planned) | 750 | $753.60 | $565,200.00 | (7%) 10.34K to 9.59K | |
| 21-Feb-24 4:26 PM View: | Greene Gabrielle E Director | Eli Lilly & Co. (LLY) | 20-Feb-24 | Grant | 13 | $755.66 | $9,823.58 | < 1% 2.08K to 2.1K | |
| 21-Feb-24 4:21 PM View: | Luciano Juan R Director | Eli Lilly & Co. (LLY) | 20-Feb-24 | Grant | 20 | $755.66 | $15,113.20 | < 1% 15.59K to 15.61K | |
| 21-Feb-24 4:24 PM View: | Hedley Mary Lynne Director | Eli Lilly & Co. (LLY) | 20-Feb-24 | Grant | 13 | $755.66 | $9,823.58 | < 1% 1.53K to 1.55K | |
| 21-Feb-24 4:18 PM View: | Johnson Kimberly H Director | Eli Lilly & Co. (LLY) | 20-Feb-24 | Grant | 13 | $755.66 | $9,823.58 | < 1% 2.58K to 2.6K | |
| 21-Feb-24 4:16 PM View: | Alvarez Ralph Director | Eli Lilly & Co. (LLY) | 20-Feb-24 | Grant | 16 | $755.66 | $12,090.60 | < 1% 53.89K to 53.91K | |
| 20-Feb-24 4:05 PM View: | Lilly Endowment Inc 10% Owner | Eli Lilly & Co. (LLY) | 16-Feb-24 | Private Sale | 169,684 | $780.99 | $132,522,000.00 | (< 1%) 99.07M to 98.9M | |
| 16-Feb-24 4:05 PM View: | Lilly Endowment Inc 10% Owner | Eli Lilly & Co. (LLY) | 15-Feb-24 | Private Sale | 50,316 | $760.46 | $38,263,400.00 | (< 1%) 99.12M to 99.07M | |
| 14-Feb-24 4:27 PM View: | Hernandez Edgardo EVP & Pres., Mfg. Operations | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 2,821 | $737.26 | $2,079,810.00 | 10% 27.72K to 30.54K | |
| 14-Feb-24 4:39 PM View: | Zakrowski Donald A SVP, Finance, & CAO | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 1,254 | $737.26 | $924,524.00 | 14% 9.08K to 10.34K | |
| 14-Feb-24 4:34 PM View: | Hakim Anat EVP, GC & Secretary | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 5,815 | $737.26 | $4,287,170.00 | 24% 24.66K to 30.48K | |
| 14-Feb-24 4:44 PM View: | White Anne E. EVP & Pres, Lilly Neuroscience | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 5,363 | $737.26 | $3,953,930.00 | 9% 60.21K to 65.57K | |
| 14-Feb-24 4:43 PM View: | Dozier Eric EVP, HR & Diversity | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 1,336 | $737.26 | $984,979.00 | 21% 6.5K to 7.84K | |
| 14-Feb-24 4:21 PM View: | Weems Alonzo EVP, ERM & CECO | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 951 | $737.26 | $701,134.00 | 14% 7.0K to 7.95K | |
| 14-Feb-24 4:41 PM View: | van Naarden Jacob EVP & Pres., Loxo@Lilly | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 2,369 | $737.26 | $1,746,570.00 | 13% 18.12K to 20.49K | |
| 14-Feb-24 4:38 PM View: | Ashkenazi Anat EVP & CFO | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 4,210 | $737.26 | $3,103,860.00 | 11% 38.31K to 42.52K | |
| 14-Feb-24 4:36 PM View: | Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 12,910 | $737.26 | $9,518,030.00 | 7% 180.83K to 193.74K | |
| 14-Feb-24 4:25 PM View: | Jonsson Patrik EVP&Pres, LLY Dia&Obe, LLY USA | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 5,362 | $737.26 | $3,953,190.00 | 13% 39.76K to 45.12K | |
| 14-Feb-24 4:43 PM View: | Dozier Eric EVP, HR & Diversity | Eli Lilly & Co. (LLY) | 12-Feb-24 | Gift | 408 | -- | -- | (5%) 7.84K to 7.43K | |
| 14-Feb-24 4:19 PM View: | Norton Johna EVP, Global Quality | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 1,668 | $737.26 | $1,229,750.00 | 5% 33.12K to 34.78K | |
| 14-Feb-24 4:29 PM View: | Yuffa Ilya EVP & President, LLY Int'l | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 4,790 | $737.26 | $3,531,480.00 | 32% 15.01K to 19.8K | |
| 14-Feb-24 4:31 PM View: | Ricks David A President, Chair, and CEO Director | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 38,392 | $737.26 | $28,304,900.00 | 7% 580.5K to 618.89K | |
| 12-Feb-24 4:05 PM View: | Lilly Endowment Inc 10% Owner | Eli Lilly & Co. (LLY) | 09-Feb-24 | Private Sale | 206,257 | $740.60 | $152,752,992.00 | (< 1%) 99.33M to 99.12M | |
| 12-Feb-24 4:16 PM View: | Ricks David A President, Chair, and CEO Director | Eli Lilly & Co. (LLY) | 08-Feb-24 | Gift | 956 | -- | -- | (< 1%) 581.45K to 580.5K | |
| 09-Feb-24 4:05 PM View: | Lilly Endowment Inc 10% Owner | Eli Lilly & Co. (LLY) | 08-Feb-24 | Private Sale | 8,743 | $740.06 | $6,470,340.00 | (< 1%) 99.33M to 99.33M | |
| 02-Feb-24 4:32 PM View: | Hakim Anat EVP, GC & Secretary | Eli Lilly & Co. (LLY) | 01-Feb-24 | Option Exercise | 4,442 | -- | -- | 20% 22.19K to 26.63K | |
| 02-Feb-24 4:20 PM View: | White Anne E. EVP & Pres, Lilly Neuroscience | Eli Lilly & Co. (LLY) | 01-Feb-24 | Option Exercise | 4,124 | -- | -- | 7% 57.93K to 62.05K | |
| 02-Feb-24 4:22 PM View: | van Naarden Jacob EVP & Pres., Loxo@Lilly | Eli Lilly & Co. (LLY) | 01-Feb-24 | Payment of Exercise | 1,685 | $645.61 | $1,087,850.00 | (9%) 19.8K to 18.12K | |
| 02-Feb-24 4:25 PM View: | Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm | Eli Lilly & Co. (LLY) | 01-Feb-24 | Payment of Exercise | 4,434 | $645.61 | $2,862,630.00 | (2%) 185.26K to 180.83K | |
| 02-Feb-24 4:26 PM View: | Jonsson Patrik EVP&Pres, LLY Dia&Obe, LLY USA | Eli Lilly & Co. (LLY) | 01-Feb-24 | Payment of Exercise | 1,844 | $645.61 | $1,190,500.00 | (4%) 41.6K to 39.76K | |
| 02-Feb-24 10:00 PM View: | Norton Johna EVP, Global Quality | Eli Lilly & Co. (LLY) | 01-Feb-24 | Payment of Exercise | 566 | $645.61 | $365,415.00 | (2%) 33.68K to 33.12K | |
| 02-Feb-24 4:29 PM View: | Yuffa Ilya EVP & President, LLY Int'l | Eli Lilly & Co. (LLY) | 01-Feb-24 | Payment of Exercise | 1,664 | $645.61 | $1,074,300.00 | (10%) 16.68K to 15.01K | |
| 02-Feb-24 4:28 PM View: | Ricks David A President, Chair, and CEO Director | Eli Lilly & Co. (LLY) | 01-Feb-24 | Payment of Exercise | 13,240 | $645.61 | $8,547,880.00 | (2%) 593.74K to 580.5K | |
| 02-Feb-24 4:22 PM View: | van Naarden Jacob EVP & Pres., Loxo@Lilly | Eli Lilly & Co. (LLY) | 01-Feb-24 | Option Exercise | 3,618 | -- | -- | 22% 16.19K to 19.8K | |
| 02-Feb-24 4:25 PM View: | Skovronsky Daniel EVP, CSO & Pres. LRL & LLY Imm | Eli Lilly & Co. (LLY) | 01-Feb-24 | Option Exercise | 9,941 | -- | -- | 6% 175.32K to 185.26K | |
| 02-Feb-24 4:26 PM View: | Jonsson Patrik EVP&Pres, LLY Dia&Obe, LLY USA | Eli Lilly & Co. (LLY) | 01-Feb-24 | Option Exercise | 4,124 | -- | -- | 11% 37.48K to 41.6K | |
| 02-Feb-24 10:00 PM View: | Norton Johna EVP, Global Quality | Eli Lilly & Co. (LLY) | 01-Feb-24 | Option Exercise | 1,268 | -- | -- | 4% 32.41K to 33.68K | |
| 02-Feb-24 4:29 PM View: | Yuffa Ilya EVP & President, LLY Int'l | Eli Lilly & Co. (LLY) | 01-Feb-24 | Option Exercise | 3,702 | -- | -- | 29% 12.97K to 16.68K | |
| 02-Feb-24 4:32 PM View: | Hakim Anat EVP, GC & Secretary | Eli Lilly & Co. (LLY) | 01-Feb-24 | Payment of Exercise | 1,967 | $645.61 | $1,269,910.00 | (7%) 26.63K to 24.66K | |
| 02-Feb-24 4:20 PM View: | White Anne E. EVP & Pres, Lilly Neuroscience | Eli Lilly & Co. (LLY) | 01-Feb-24 | Payment of Exercise | 1,844 | $645.61 | $1,190,500.00 | (3%) 62.05K to 60.21K |
